Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
4.09M
-
Shares change
-
-674K
-
Total reported value, excl. options
-
$14.8M
-
Value change
-
-$3.21M
-
Put/Call ratio
-
1.57
-
Number of buys
-
9
-
Number of sells
-
-14
-
Price
-
$3.63
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2020
35 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q4 2020.
Protalix BioTherapeutics, Inc. - COM (PLX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.09M shares
.
Largest 10 shareholders include Burrage Capital Management LLC (2.47M shares), RENAISSANCE TECHNOLOGIES LLC (489K shares), Psagot Investment House Ltd. (470K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (213K shares), UBS OCONNOR LLC (150K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (66.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (55.6K shares), GROUP ONE TRADING, L.P. (50.3K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (23.4K shares), and JANE STREET GROUP, LLC (22.2K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.